Check-Cap Ltd. (CHEK): Price and Financial Metrics
GET POWR RATINGS... FREE!
CHEK Stock Price Chart Interactive Chart >
CHEK Price/Volume Stats
|Current price||$1.63||52-week high||$4.49|
|Prev. close||$1.64||52-week low||$0.24|
|Day high||$1.65||Avg. volume||14,814,671|
|50-day MA||$1.54||Dividend yield||N/A|
|200-day MA||$1.10||Market Cap||75.37M|
Check-Cap Ltd. (CHEK) Company Bio
Check-Cap Ltd. is a clinical stage medical diagnostics company engaging in the development of ingestible imaging capsule system for colorectal cancer screening. The company was founded by Yoav Kimchy in April 2005 and is headquartered in Isfiya, Israel.
CHEK Latest News Stream
|Loading, please wait...|
CHEK Latest Social Stream
View Full CHEK Social Stream
Latest CHEK News From Around the Web
Below are the latest news stories about Check-Cap Ltd that investors may wish to consider to help them evaluate CHEK as an investment opportunity.
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Check-Cap Ltd. (the "Company" or "Check-Cap") (NASDAQ: CHEK) (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the development of the C-Scan®, the first and only patient-friendly preparation-free screening test to detect polyps before they may transform into cancer, today announced that it has entered into a definitive agreement with several existing institutional investors for the exercise of certain outstanding warrants to purchase up to an aggregate of 16,054,223 of its ordinary shares at a reduced exercise price of $0.60 per share. The warrants being exercised were issued by Check-Cap on several dates from November 2017 through May 2020 and have exercise prices ranging from $15.00 to $0.80 per share.
CHEK Price Returns